CRP Sante
1
6M
1
0.03
- Stages of investment
- Areas of investment
Summary
CRP Sante appeared to be the Corporate Investor, which was created in 1988. The company was established in Europe in Luxembourg. The main department of described Corporate Investor is located in the Strassen.
The usual cause for the fund is to invest in rounds with 3 partakers. The meaningful sponsors for the fund in investment in the same round are Vesalius Biocapital Partners, Limburgse Reconversie Maatschappij. In the next rounds fund is usually obtained by Omnes Capital, Vinnof, Vesalius Biocapital Partners.
For fund there is no match between the country of its foundation and the country of its the most frequent investments - Belgium. Moreover, a startup needs to be at the age of 2-3 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Complix. Among the most successful fund investment fields, there are Biotechnology, Therapeutics.
The fund is generally included in less than 2 deals every year. Deals in the range of 5 - 10 millions dollars are the general things for fund. The top activity for fund was in 2010.
Investments analytics
Analytics
- Total investments
- 1
- Lead investments
- 0
- Rounds per year
- 0.03
- Investments by industry
- Health Care (1)
- Therapeutics (1)
- Biotechnology (1)
- Investments by region
-
- Belgium (1)
- Peak activity year
- 2010
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 13
- Group Appearance index
- 1.00
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Complix | 10 Jun 2010 | Biotechnology, Health Care, Therapeutics | Early Stage Venture | 6M | Belgium, Limburg |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.